A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Clinical trial NCT07190261 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07190261
- Sponsor
- Bing Han
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-18
- Primary completion
- 2027-09-18
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.